We found when the proportion of ER is less than 25%, 18F-FDG PET/CT may be better at detecting unsuspected extraaxillary lymph node metastasis in breast cancer patients and changing the initial treatment plan, so as to help 18F-FDG PET/CT get better application and help breast cancer patients get better diagnosis and treatment. This evidence concerns the gene ESR1 and breast carcinoma.